Stephan Ladisch, M.D., professor of pediatrics and professor of biochemistry and molecular biology, was featured in Medical Xpress for recently published research in the American Society of Hematology journal, Blood. The international study found that prolonged, intense initial treatment in children with multi-system Langerhans cell histiocytosis (MS-LCH) can achieve survival rates as high as 84 percent—a full 15 percent improvement over his previous clinical trial. This research was also featured in Science Codex.
Medical Xpress - Study Shows Longer Treatment for Children With Langerhans Cell Hystiocytosis Improves Survival Rates
Latest News
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the GW Medical Faculty Associates (GW MFA) are pleased to announce that Jocelyn Rapelyea, MD, RESD ’00, will serve as the chair of the GW Department of Radiology. She has served as interim chair since March 2025…
Anthony S. Fauci, MD, former director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), delivered the keynote address to open the 12th annual George Washington University School of Medicine and Health Sciences (SMHS) Clinical Public…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the appointment of Lorenzo Norris, MD, FACP, to a new leadership role, Senior Associate Dean for Education, effective Jan. 5, 2026.